Now USA operations are running at a net loss. There is no P.E ratio. They can plan n plan, but need to secure NYC casino license first then got story theme to IPO mah ... so we need to wait
Good. 16,000 investors have watched 'The Transformation of Genting is Just Starting' on YouTube.
Message from Genting's top management: Genting Berhad is one of the rare companies globally. We have built and operated new casinos 20 years after our rivals in the Las Vegas market, which is one of the most competitive in the world. Since opening our doors, unlike others who initially suffered losses, we have never experienced EBITDA losses. Our success is due to the highly credible team we've built in the gaming industry..
In essence, the management wants to convey confidence in their unique market position, consistent success, strong team, and readiness for future growth through the US IPO. Akan datang..
For the past 3 yrs, this stock mostly trading between 4.30 to 5.30, with mid-point at 4.80. Hence below 4.80 could also be considered "cheap" relative to past 3 yrs of stock price performance.
Genting’s Oil Kasuri operates the Asap-Kido Merah gas field’s concession in Indonesia’s West Papua province that was secured back in 2008.
“We deem that Genting’s Oil Kasuri will supply the feed natural gas to this FLNG project operated by PTLNG, where natural gas can be extracted from the reservoir and converted into 1.2 mpta LNG for exports. The Kasuri has the potential of 1.7 trillion cubic feet of gas reserves.
云顶的美国业务包括: - 50亿美元(约236亿令吉)的美国拉斯维加斯云顶世界(Resorts World Las Vegas), - 并通过子公司云顶大马(GENM,4715,主要板消费)营运着 - 纽约云顶世界 (Resorts World New York City)、 - 卡茨基尔云顶世界 (Resorts World Catskills), - 以及哈德逊河谷的云顶世界 (Resorts World Hudson Valley)。
Therefore, the potential value of the Kasuri gas reserves, when converted to LNG for export over the project's lifetime and considering a 20% profit margin, is estimated to be approximately $21.216 billion.
Regarding the Kasuri gas reserves and the FLNG project operated by PTLNG, the involvement of Genting Berhad in the oil and gas sector would be through its subsidiary, Genting Oil & Gas. Here’s a summary of relevant details:
Kasuri Block: Located in West Papua, Indonesia, this block has substantial natural gas reserves estimated at 1.7 trillion cubic feet. Genting Oil & Gas has been developing this block with the potential to supply natural gas for various purposes, including LNG production. Kasuri Gas Reserves and FLNG Project Natural Gas Reserves: 1.7 trillion cubic feet (Tcf) of gas reserves in the Kasuri Block. FLNG Project: A Floating Liquefied Natural Gas (FLNG) facility operated by PTLNG, which will process the natural gas into LNG for export. LNG Production Capacity: 1.2 million tonnes per annum (mtpa) of LNG. Estimated Value and Profit Margin To recap the value estimation with a 20% profit margin:
Conversion to LNG:
1.7 Tcf of natural gas can produce approximately 34 million tonnes of LNG. Revenue Calculation:
Assuming an average LNG price of $10/MMBtu and 1 tonne of LNG being approximately equal to 52 MMBtu, the revenue per tonne is $520. Total revenue from 34 million tonnes of LNG is $17.68 billion. Profit Margin:
Adding a 20% profit margin, the potential value is approximately $21.216 billion. This significant value underscores the importance of the Kasuri gas reserves and the strategic role of Genting Berhad in the global energy market. The development of the Kasuri Block and the FLNG project demonstrates the company's commitment to leveraging its resources and expertise in the oil and gas industry.
Foreign fund is rescheduling portfolio for Q2 results, it seems. However nett selling is still dominant. Genting share price is highly depend on foreign funds. Foreign fund nett buying(+)/ selling (-): 20JUN-65M, 21JUN-176M, 24JUN-164M, 25JUN-76M, 26JUN+18M, 27JUN-266M, 28JUN+133M. We can compare foreign fund movement with Genting share price to check if any correlation. (Foreign fund continue to nett sell 266M yesterday, turning point not yet seen. Genting range bound between 4.65-4.85 until a good/bad news which have material effect may break this range bound)
I think having the US IPO under GenM will generally benefit GenM instead of GenB.. the US IPO under GenM is likely to bring significant benefits to GenM, positioning it for growth and enhanced market presence.
If Boss Lim announces tomorrow that the US IPO will be under GenM, GenM's share price is likely to surge.. Genting's shareholders might then overlook the RPT issues, high pay and other concerns.
Posted by Michaelchan2024 > 1 hour ago | Report Abuse @ATK, you mentioned you don't hold any Genting shares. However, what puzzles me is why you are here on the Genting forum? -----------
Still observing price action and reaction so my trading skill not rusty + how the crowd is thinking for this stock. To become a better boyfriend, you need to understand your girlfriend very well. To trade a stock well, you need to understand the behaviour of the stock well. I still manage to nail the important top (5.20 zone) and bottom (4.45 zone) for this stock during 2024. Call this a trader's life long learning process, Im forever a student of the stock market. I treat this business very seriously. I trade to win money.
No money now, all showhand into Taurx, which I believe can give me much higher returns than stock trading. But some day I will take back all my Taurx investment capital and start stock trading business again.
Bus crash.. Down... Fire incident.. Down... Tourist arrivals dissapointment... Down.. Last time batang kali landslide incident... Down... Then when it will up... Aduhai
TauRx Pharmaceuticals Ltd, a global leader in tau-based research in Alzheimer’s disease (AD), has announced the submission of a UK Marketing Authorisation Application (MAA) for hydromethylthionine mesylate (HMTM) for treatment of mild cognitive impairment (MCI-AD) and mild to moderate stages of dementia due to Alzheimer’s disease.
HMTM has been designated by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) for the Innovative Licensing and Access Pathway (ILAP). If successful, the UK could be the first country in which an accessible, safe, oral treatment, which targets the hallmark tau pathology of the disease, becomes available to patients.
The MAA is based on the totality of evidence available from the recently released 24-month Phase 3 LUCIDITY data and two earlier Phase 3 trials in mild to moderate AD. These studies have been consistent in showing benefit on measures of decline in cognition, ability to perform normal activities of daily living, and reduction in the rate of brain shrinkage.
Tau aggregation is strongly correlated with the rate and severity of cognitive decline, brain atrophy, and the damage to neurons responsible for the characteristic neurodegeneration of the disease. HMTM acts by selectively inhibiting the aggregation of tau-protein in brain nerve cells. It also has a second mode of action which results in enhancement of brain functioning.
Commenting on the submission, Professor Claude Wischik, Executive Chairman of TauRx, said: “This is a significant milestone for TauRx and is an important step in potentially bringing a new type of treatment and a new hope to patients and families who carry the burden of this terrible disease.”
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
Michaelchan2024
1,232 posts
Posted by Michaelchan2024 > 2024-06-28 16:49 | Report Abuse
Kepo kepo only..but always sincere ♥️